Showing Results for: “diabetes”

Cycling event raises funds to support diabetes research, local programming, and advocacy efforts On February 14, the American Diabetes Association ® (ADA) will host its 2026 Tour de Cure ®: Arizona. This cycling fundraiser will bring together individuals, families, organizations, and corporations for a ride in support of people living with diabetes. Time and date: Saturday, February 14 from 7:00 a.m.–2:00 p.m. Location: Goodyear Ballpark, 1933 S Ballpark Way, Goodyear, AZ 85338 Registration: Participants can register, start or join a team, and fundraise at diabetes.org/ArizonaTour. “In Arizona

Top researchers, clinicians and educators will be recognized at the 79th Scientific Sessions for outstanding leadership and work to advance diabetes research, prevention, care and treatment The American Diabetes Association (ADA) is proud to announce the recipients of the ADA’s 2019 National Scientific and Health Care Achievement Awards. Individually and collectively, their exemplary leadership, mentorship and many achievements have advanced the field of diabetes care and improved health outcomes for people living with diabetes. “This year’s National Scientific and Health Care Achievement

Leading diabetes researchers and clinicians from around the world highlight impact of health disparities on diabetes care The American Diabetes Association® (ADA) is highlighting the latest understanding of how to address health disparities laid bare by the pandemic at the virtual 81st Scientific Sessions. Taking place June 25–29, the ADA’s Scientific Sessions is the world’s largest scientific meeting focused on diabetes research, prevention, and care. These expert discussions come at a time when 76% of Americans currently living in poverty are people of color. Diabetes prevalence is inversely

Today, the American Diabetes Association ® (ADA) submitted its official public comment on the White House Office of Management and Budget (OMB) proposed rule on the Guidance for Federal Financial Assistance. In its comment, the ADA expressed significant concern over the proposed rule stating “Overarchingly, we are concerned that the collective policies in the proposed rule, if finalized, will have a detrimental impact on the ability for researchers and chronic disease prevention programs to initiate or continue engaging in critical, life-saving scientific research that support the prevention

New Research Demonstrates Significant Benefits of Simple Dietary Switch for Blood Glucose Control and Long-Term Weight Management Consistently replacing diet beverages with water in women with type 2 diabetes may contribute to greater weight loss and increases the likelihood of long-term diabetes remission. The results were presented as a general poster at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago. Everyday, approximately one-fifth of the U.S. population consumes a diet drink. Regular consumption of diet beverages has been linked to a range of

The American Diabetes Association ® (ADA) welcomes the 2022 Principal Officers and Board of Directors. The 13-member board is comprised of forward-thinking, innovative medical, scientific, education and executive business professionals, who will strategically lead and focus efforts to ensure the ADA continues to uphold the mission upon which it was founded. "We are so excited to announce our 2022 Board of Directors, including four new Board members,” said ADA’s Office of the CEO. “We look forward to the insight and skills that each of these thought leaders will provide to help move the needle

New Program Will Cap Medicare Monthly Co-Pays at $35 Today, the American Diabetes Association (ADA) joined the Centers for Medicare and Medicaid Services (CMS) for a White House event to announce the Part D Senior Savings Model, which will limit the cost of insulin for participating seniors to a maximum of $35 for a 30-day supply. “Together, we are helping 3.3 million seniors access insulin more affordably through significant caps on out-of-pocket co-pays,” said Tracey D. Brown, CEO of the American Diabetes Association. “The American Diabetes Association – the nation’s leading organization for

The American Diabetes Association® (ADA) applauds Senators Jeanne Shaheen, Susan Collins, Raphael Warnock, and John Kennedy for introducing the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2026. This is critical, bipartisan legislation that will make insulin more affordable and accessible for millions of Americans. Over 40 million Americans live with diabetes, and over 8 million people rely on insulin to survive. Diabetes is one of the most expensive chronic conditions in the United States, accounting for one in every four health care dollars spent

Results of NIDDK’s, Fuzzy Logic Automated Insulin Regulation (FLAIR) study showed increased time in range and improved A1C levels in adolescents and young adults who used system Medtronic’s Advanced Hybrid Closed-Loop system use in adolescents and young adults with type 1 diabetes (T1D) can lead to improved daytime blood sugar control without an increase in hypoglycemia, according to research presented today at the American Diabetes Association’s® (ADA’s) 80th Scientific Sessions. The presentation, “FLAIR—An NIDDK-Sponsored International, Multi-site Randomized Crossover Trial of AHCL vs. 670G

The American Diabetes Association (ADA) is honored to welcome the 2019 Principal Officers and Board of Directors. The 18-member board is comprised of forward-thinking medical, scientific, education and executive professionals, who will strategically lead and focus efforts to ensure the ADA continues to be synonymous with excellence. "The newest members of ADA’s National Board of Directors are respected and trusted leaders within their professions, and we are thankful they are willing to share their time and energy to help us bend the curve on the diabetes epidemic,” said Tracey D. Brown, Chief